Pancreatic cyst features predict future development of pancreatic cancer: results of a nested case-control study
- PMID: 37858759
- PMCID: PMC10865337
- DOI: 10.1016/j.gie.2023.10.038
Pancreatic cyst features predict future development of pancreatic cancer: results of a nested case-control study
Abstract
Background and aims: Risk factors for pancreatic cancer among patients with pancreatic cysts are incompletely characterized. The primary aim of this study was to evaluate risk factors for development of pancreatic cancer among patients with pancreatic cysts.
Methods: We conducted a retrospective case-control study of U.S. veterans with a suspected diagnosis of branch-duct intraductal papillary mucinous neoplasm from 1999 to 2013.
Results: Age (hazard ratio [HR], 1.03 per year; 95% confidence interval [CI], 1.00-1.06), larger cyst size at cyst diagnosis (HR, 1.03 per mm; 95% CI, 1.01-1.04), cyst growth rate (HR, 1.22 per mm/y; 95% CI, 1.14-1.31), and pancreatic duct dilation (5-9.9 mm: HR, 3.78; 95% CI, 1.90-7.51; ≥10 mm: HR, 13.57; 95% CI, 5.49-33.53) were found to be significant predictors for pancreatic cancer on multivariable analysis.
Conclusions: Age, cyst size, cyst growth rate, and high-risk or worrisome features were associated with a higher risk of developing pancreatic cancer. Applying current and developing novel strategies is required to optimize early detection of pancreatic cancer after cyst diagnosis.
Published by Elsevier Inc.
Conflict of interest statement
Disclosure The following authors received research support for this study from the 2017 American College of Gastroenterology Clinical Research Award, the U.S. Department of Veterans Affairs Health Services Research & Development Service of the Veterans Affairs Office of Research and Development (grant I01 HX001574-05), and the National Cancer Institute (grant R37 CA222866-03): S. Gupta; and the National Institute of Diabetes and Digestive and Kidney Diseases (grant P30 DK 120515-02): Schnabl. In addition, the following author disclosed financial relationships: S. Fehmi: Consultant for Boston Scientific and Cook Medical. All other authors disclosed no financial relationships.
Figures

Comment in
-
Different cancers in the same basket: intraductal papillary mucinous neoplasm-derived versus concomitant pancreatic carcinomas.Gastrointest Endosc. 2024 Apr;99(4):662-663. doi: 10.1016/j.gie.2023.11.002. Gastrointest Endosc. 2024. PMID: 38508811 No abstract available.
References
-
- Kromrey ML, Bülow R, Hübner J, et al. Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut 2018;67:138–45. - PubMed
-
- Tanaka M, Fernández-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017;17:738–53. - PubMed
-
- Vege SS, Ziring B, Jain R, et al. American Gastroenterological Association Institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 2015;148:819–22; quiz e12–3. - PubMed